Journal of Pharmaceutical and Biomedical Analysis 1996-05-01

Assay and purity evaluation of 5-chlorooxindole by liquid chromatography.

S T Colgan, G R Haggan, R H Reed

文献索引：J. Pharm. Biomed. Anal. 14(7) , 825-33, (1996)

全文：HTML全文

摘要

5-Chlorooxindole (5-CO) is a starting material for tenidap sodium, a pharmaceutical drug candidate produced by Pfizer. To insure potency and purity of the drug substance, it is necessary to demonstrate that commercial supplies of 5-CO are free from elevated levels of chemical analogs that could be carried through the synthetic scheme. This is accomplished using a single highly specific normal-phase chromatographic system that allows the quantitation of 5-CO concomitantly with all of its potential positional isomers. This paper describes the chromatographic system and its supportive validation data.